| Autor: |
Magi GE; School of Biosciences and Veterinary Medicine, University of Camerino, 62024 Matelica, Italy., Mariotti F; School of Biosciences and Veterinary Medicine, University of Camerino, 62024 Matelica, Italy., Pallotta L; School of Biosciences and Veterinary Medicine, University of Camerino, 62024 Matelica, Italy., Di Cerbo A; School of Biosciences and Veterinary Medicine, University of Camerino, 62024 Matelica, Italy., Venanzi FM; CureLab Oncology Inc., Dedham, MA 02026, USA. |
| Jazyk: |
angličtina |
| Zdroj: |
Animals : an open access journal from MDPI [Animals (Basel)] 2022 Aug 02; Vol. 12 (15). Date of Electronic Publication: 2022 Aug 02. |
| DOI: |
10.3390/ani12151964 |
| Abstrakt: |
The p62 protein, also called sequestosome 1 (SQSTM1), is a ubiquitin-binding scaffold protein. In human oncology, although the interest in the function of this protein is recent, the knowledge is now numerous, but its role in tumorigenesis is not yet clear. This preliminary study aims to evaluate the immunohistochemical expression of p62 in 38 cases of feline mammary carcinoma with different grades of differentiation and in 12 non-neoplastic mammary gland tissues, to assess the expression level and a possible correlation with malignancy. The expression of p62 was statistically higher in carcinoma compared to non-neoplastic mammary glands: 28 feline mammary carcinomas (73.7%) had a high p62 expression score, three (7.9%) had a moderate expression, while seven cases (18.4%) had a low expression. The grade of the differentiation of the carcinoma was not correlated with the p62 expression. This study represents the first approach in feline oncology that correlates p62 expression in feline mammary carcinoma. Our results, although preliminary, are similar to the results of human breast cancer, therefore, also in the cat, p62 could be considered a possible oncotarget. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
